{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T15:09:41Z","timestamp":1778944181771,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003153","name":"GEOMAR Helmholtz-Zentrum f\u00fcr Ozeanforschung Kiel","doi-asserted-by":"publisher","award":["WO2020\/043771 A1"],"award-info":[{"award-number":["WO2020\/043771 A1"]}],"id":[{"id":"10.13039\/501100003153","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003153","name":"GEOMAR Helmholtz-Zentrum f\u00fcr Ozeanforschung Kiel","doi-asserted-by":"publisher","award":["EP 3 617 709 A1"],"award-info":[{"award-number":["EP 3 617 709 A1"]}],"id":[{"id":"10.13039\/501100003153","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009318","name":"Helmholtz Association","doi-asserted-by":"publisher","award":["HV-0048"],"award-info":[{"award-number":["HV-0048"]}],"id":[{"id":"10.13039\/501100009318","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.bone.2025.117522","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T07:57:12Z","timestamp":1747123032000},"page":"117522","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Monitoring denosumab therapy using the calcium isotope marker (CIM) technology"],"prefix":"10.1016","volume":"198","author":[{"given":"Anton","family":"Eisenhauer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00f6nke","family":"S\u00f6nnichsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agustina","family":"Hastuti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rukshana","family":"Shroff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Heuser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Kolevica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amarin","family":"Lubnow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Burkard","family":"Brandt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2025.117522_bb0005","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1210\/jc.2007-2814","article-title":"Effects of denosumab on bone mineral density and bone turnover in postmenopausal women","volume":"93","author":"Bone","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2025.117522_bb0010","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.bone.2025.117522_bb0015","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/jbmr.1479","article-title":"Five years of denosumab exposure in women with postmenopausal osteoporosis: results from the first two years of the FREEDOM extension","volume":"27","author":"Papapoulos","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2025.117522_bb0020","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0140-6736(10)62344-6","article-title":"Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study","volume":"377","author":"Fizazi","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.bone.2025.117522_bb0025","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S1470-2045(19)30687-4","article-title":"Adjuvant denosumab in early breast cancer (D-CARE): an international, multicentre, randomised, controlled, phase 3 trial","volume":"21","author":"Coleman","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bone.2025.117522_bb0030","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1188\/11.ONF.237-238","article-title":"Denosumab injection approved for skeletal injury prevention","volume":"38","author":"Smart","year":"2011","journal-title":"Oncol. Nurs. Forum"},{"key":"10.1016\/j.bone.2025.117522_bb0035","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s00198-015-3335-3","article-title":"Osteonecrosis of the jaw (ONJ): diagnosis and management in 2015","volume":"27","author":"Khan","year":"2016","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2025.117522_bb0040","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1056\/NEJMoa1916525","article-title":"Atypical femur fracture risk versus fragility fracture prevention with bisphosphonates","volume":"383","author":"Black","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2025.117522_bb0045","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bone.2017.08.003","article-title":"Discontinuation of denosumab therapy for osteoporosis: a systematic review and position statement by ECTS","volume":"105","author":"Tsourdi","year":"2017","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.bone.2025.117522_bb0050","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1210\/jc.2016-3170","article-title":"Severe rebound-associated vertebral fractures after denosumab discontinuation: 9 clinical cases report","volume":"102","author":"Lamy","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.bone.2025.117522_bb0055","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/jbmr.3337","article-title":"Vertebral fractures after discontinuation of denosumab: a post hoc analysis of the randomized placebo-controlled FREEDOM trial and its extension","volume":"33","author":"Cummings","year":"2018","journal-title":"J. Bone Miner. Res."},{"issue":"2","key":"10.1016\/j.bone.2025.117522_bb0060","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1373\/clinchem.2016.259085","article-title":"Bone turnover markers in the diagnosis and monitoring of metabolic bone disease","volume":"63","author":"Greenblatt","year":"2017","journal-title":"Clin. Chem."},{"issue":"10","key":"10.1016\/j.bone.2025.117522_bb0065","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgae224","article-title":"Zoledronate after denosumab discontinuation: is repeated administrations more effective than single infusion?","volume":"109","author":"Grassi","year":"2024","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2025.117522_bb0075","article-title":"Calcium isotope ratios in blood and urine: a new biomarker for the diagnosis of osteoporosis","volume":"10","author":"Eisenhauer","year":"2019","journal-title":"Bone Rep."},{"key":"10.1016\/j.bone.2025.117522_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2024.117210","article-title":"Calcium isotope composition in serum and urine for the assessment of bone mineral balance (BMB) \u2013 the osteolabs post-market follow-up study","volume":"188","author":"Eisenhauer","year":"2024","journal-title":"Bone"},{"key":"10.1016\/j.bone.2025.117522_bb0085","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1039\/C7MT00255F","article-title":"Calcium isotope signature: new proxy for net change in bone volume for chronic kidney disease and diabetic rats","volume":"9","author":"Tanaka","year":"2017","journal-title":"Metallomics"},{"key":"10.1016\/j.bone.2025.117522_bb0090","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.kint.2022.04.024","article-title":"Naturally occurring stable calcium isotope ratios are a novel biomarker of bone calcium balance in chronic kidney disease","volume":"102","author":"Shroff","year":"2022","journal-title":"Kidney Int."},{"key":"10.1016\/j.bone.2025.117522_bb0095","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.bone.2009.11.037","article-title":"A pilot study on the use of natural calcium isotope (44Ca\/40Ca) fractionation in urine as a proxy for the human body calcium balance","volume":"46","author":"Heuser","year":"2010","journal-title":"Bone"},{"key":"10.1016\/j.bone.2025.117522_bb0100","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/jbmr.4158","article-title":"Naturally occurring stable calcium isotope ratios in body compartments provide a novel biomarker of bone mineral balance in children and young adults","volume":"36","author":"Shroff","year":"2021","journal-title":"J. Bone Miner. Res."},{"issue":"2","key":"10.1016\/j.bone.2025.117522_bb0105","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1530\/EJE-20-0348","article-title":"Early effects of androgen deprivation on bone and mineral homeostasis in adult men: a prospective cohort study","volume":"183","author":"Khalil","year":"2020","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.bone.2025.117522_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ebiom.2023.104817","article-title":"Changes in bone and mineral homeostasis after short-term androgen deprivation therapy with or without androgen receptor signalling inhibitor \u2013 substudy of a single-centre, double blind, randomised, placebo-controlled phase 2 trial","volume":"97","author":"David","year":"2023","journal-title":"Ebiomedicine"},{"key":"10.1016\/j.bone.2025.117522_bb0115","author":"Dachverband Osteologie e.V"},{"key":"10.1016\/j.bone.2025.117522_bb0120","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1007\/s00198-017-4082-4","article-title":"Use of CTX-I and PINP as bone turnover markers: national bone health alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability","volume":"28","author":"Szulc","year":"2017","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2025.117522_bb0125","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nrrheum.2012.86","article-title":"Bone turnover markers: use in osteoporosis","volume":"8","author":"Naylor","year":"2012","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.bone.2025.117522_bb0130","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/PL00005830","article-title":"Serum CTX: a new marker of bone resorption that shows treatment effect more often than other markers because of low coefficient of variability and large changes with bisphosphonate therapy","volume":"66","author":"Rosen","year":"2000","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2025.117522_bb0135","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.bonr.2018.03.006","article-title":"Denosumab significantly improves lumbar spine bone mineral density more in treatment-na\u00efve than in long-term bisphosphonate-treated patients","volume":"8","author":"Suzuki","year":"2018","journal-title":"Bone Rep."},{"key":"10.1016\/j.bone.2025.117522_bb0140","doi-asserted-by":"crossref","DOI":"10.1093\/jbmrpl\/ziaf032","article-title":"Calcium isotope ratio in patients with monogenic bone diseases \u2013 a prospective, cross sectional, single center pilot study","author":"Munzinger","year":"2025","journal-title":"JBMR Plus"},{"key":"10.1016\/j.bone.2025.117522_bb0145","doi-asserted-by":"crossref","DOI":"10.1093\/jbmr\/zjaf004","article-title":"The effect of calcium supplementation on bone calcium balance and calcium and bone metabolism during load carriage in women: a randomized controlled crossover trial","author":"Coombs","year":"2025","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2025.117522_bb0150","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00198-010-1501-1","article-title":"Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards","volume":"22","author":"Vasikaran","year":"2011","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2025.117522_bb0155","doi-asserted-by":"crossref","first-page":"111","DOI":"10.14740\/jem810","article-title":"Hypocalcemia after the administration of denosumab in a patient with osteoporotic fracture and vitamin D deficiency","volume":"12","author":"Kim","year":"2022","journal-title":"J. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2025.117522_bb0160","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ctrv.2012.07.002","article-title":"Denosumab in patients with cancer and skeletal metastases: a systematic review and meta-analysis","volume":"39","author":"Peddi","year":"2013","journal-title":"Cancer Treat. Rev."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328225001346?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328225001346?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T14:17:52Z","timestamp":1778941072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328225001346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":31,"alternative-id":["S8756328225001346"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2025.117522","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monitoring denosumab therapy using the calcium isotope marker (CIM) technology","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2025.117522","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117522"}}